Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 2 Systolic Hypertension”

17 trials

Showing 17 of 17 results

Large-scale testing (Phase 3)Study completedNCT00350168
What this trial is testing

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Who this might be right for
Hypertension
Novartis 647
Post-approval studies (Phase 4)Study completedNCT00942994
What this trial is testing

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Who this might be right for
Hypertension
Novartis 412
Post-approval studies (Phase 4)Study completedNCT00760266
What this trial is testing

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

Who this might be right for
Hypertension
Novartis 451
Post-approval studies (Phase 4)Study completedNCT00739596
What this trial is testing

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

Who this might be right for
Hypertension
Novartis Pharmaceuticals 332
Post-approval studies (Phase 4)WithdrawnNCT01922141
What this trial is testing

Aliskiren Study of Safety and Efficacy in Senior Hypertensives

Who this might be right for
Hypertension
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00759551
What this trial is testing

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Takeda 555
Post-approval studies (Phase 4)Study completedNCT00853957
What this trial is testing

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Who this might be right for
Hypertension
Novartis 443
Post-approval studies (Phase 4)Study completedNCT00787605
What this trial is testing

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

Who this might be right for
HypertensionDiabetes Mellitus
Novartis 860
Post-approval studies (Phase 4)Study completedNCT00772577
What this trial is testing

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension

Who this might be right for
Hypertension
Novartis 386
Post-approval studies (Phase 4)Study completedNCT00797316
What this trial is testing

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

Who this might be right for
Hypertension
Novartis 532
Testing effectiveness (Phase 2)Ended earlyNCT00802893
What this trial is testing

Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction

Who this might be right for
Isolated Systolic HypertensionEndothelial Dysfunction
Johns Hopkins University 3
Post-approval studies (Phase 4)Study completedNCT00931710
What this trial is testing

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Who this might be right for
Stage 2 Systolic Hypertension
Novartis 488
Post-approval studies (Phase 4)Study completedNCT00927394
What this trial is testing

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

Who this might be right for
Hypertension
Novartis 1,143
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc
Post-approval studies (Phase 4)Study completedNCT00185068
What this trial is testing

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Who this might be right for
Hypertension
Daiichi Sankyo 110
Large-scale testing (Phase 3)Study completedNCT00353912
What this trial is testing

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Who this might be right for
Hypertension
Novartis 571
Post-approval studies (Phase 4)Study completedNCT01057251
What this trial is testing

Nebivolol in Patients With Systolic Stage 2 Hypertension

Who this might be right for
Hypertension
Forest Laboratories 433

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation